Omega Healthcare Investors - OHI Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Omega Healthcare Investors in the last twelve months. There are currently 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OHI, but not buy additional shares or sell existing shares.
View OHI analyst ratings or view top-rated stocks.

10 equities research analysts have issued twelve-month price objectives for Omega Healthcare Investors' stock. Their OHI share price forecasts range from $28.00 to $36.00. On average, they anticipate the company's share price to reach $32.00 in the next year. This suggests that the stock has a possible downside of 3.3%.
View analysts price targets for OHI or view top-rated stocks among Wall Street analysts.

Omega Healthcare Investors' stock was trading at $29.59 at the start of the year. Since then, OHI shares have increased by 11.9% and is now trading at $33.10.
View the best growth stocks for 2022 here.

Omega Healthcare Investors saw a decrease in short interest in July. As of July 15th, there was short interest totaling 17,250,000 shares, a decrease of 16.8% from the June 30th total of 20,730,000 shares. Based on an average trading volume of 2,570,000 shares, the days-to-cover ratio is presently 6.7 days. Approximately 7.4% of the shares of the company are short sold.
View Omega Healthcare Investors' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our OHI earnings forecast.

Omega Healthcare Investors, Inc. (NYSE:OHI) issued its quarterly earnings data on Monday, August, 1st. The real estate investment trust reported $0.38 EPS for the quarter, missing the consensus estimate of $0.73 by $0.35. The real estate investment trust earned $207.54 million during the quarter, compared to analyst estimates of $220.06 million. Omega Healthcare Investors had a trailing twelve-month return on equity of 11.00% and a net margin of 44.01%. The company's quarterly revenue was down 4.8% on a year-over-year basis. During the same quarter last year, the company posted $0.85 earnings per share.

Omega Healthcare Investors declared a quarterly dividend on Friday, July 22nd. Stockholders of record on Monday, August 1st will be paid a dividend of $0.67 per share on Monday, August 15th. This represents a $2.68 dividend on an annualized basis and a yield of 8.10%. The ex-dividend date of this dividend is Friday, July 29th.
Read our dividend analysis for OHI.

Omega Healthcare Investors (NYSE:OHI) pays an annual dividend of $2.68 per share and currently has a dividend yield of 8.07%. OHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 141.80%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, OHI will have a dividend payout ratio of 88.74% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for OHI.

3 employees have rated Omega Healthcare Investors Chief Executive Officer C. Taylor Pickett on Glassdoor.com. C. Taylor Pickett has an approval rating of 56% among the company's employees. This puts C. Taylor Pickett in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Healthcare Investors investors own include AT&T (T), Enterprise Products Partners (EPD), Verizon Communications (VZ), Energy Transfer (ET), Realty Income (O), Cisco Systems (CSCO), AbbVie (ABBV), Annaly Capital Management (NLY), New Residential Investment (NRZ) and Pfizer (PFE).

Omega Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "OHI."

Omega Healthcare Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include JPMorgan Chase & Co. (0.66%), abrdn plc (0.66%), Deutsche Bank AG (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.39%), Principal Financial Group Inc. (0.40%) and Rhumbline Advisers (0.31%). Insiders that own company stock include Burke W Whitman, Burke W Whitman, C Taylor Pickett, Craig R Callen, Daniel J Booth, Kapila K Anand, Michael Ritz, Neal Ballew, Robert O Stephenson and Steven J Insoft.
View institutional ownership trends.

Shares of OHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OHI stock can currently be purchased for approximately $33.10.

Omega Healthcare Investors (NYSE:OHI) has a market capitalization of $7.75 billion and generates $1.06 billion in revenue each year. The real estate investment trust earns $416.74 million in net income (profit) each year or $1.89 on an earnings per share basis.

Omega Healthcare Investors' mailing address is 303 International Circle Suite 200, HUNT VALLEY MD, 21030. The official website for the company is www.omegahealthcare.com. The real estate investment trust can be reached via phone at (410) 427-1700, via email at mgourmand@omegahealthcare.com, or via fax at 410-427-8800.